C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
02/1994
02/23/1994	EP0583960A2 Synthesis of bicyclic aromatic sulfonic acids, sulfonyl chlorides and sulfonamides
02/21/1994	EP0594624A4 Dynemicin analogs: syntheses, methods of preparation and use.
02/20/1994	CA2103930A1 Synthesis of bicyclic aromatic sulfonic acids, sulfonyl chlorides and sulfonamides
02/16/1994	EP0582581A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO 4,5-c]QUINOLIN-4-AMINES
02/15/1994	US5286709 Herbicides, plant growth regulators
02/09/1994	EP0581939A1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
02/09/1994	EP0581777A1 Stereoselective preparation of substituted piperidines
02/09/1994	CN1081677A Substituted Phenylcarbamates and ureas
02/09/1994	CN1081669A Compounds for the treatment of nemodegenerative disorders
02/02/1994	EP0580812A1 Anti-tumor and anti-psoriatic agents
02/02/1994	EP0580616A1 New active compounds
02/02/1994	EP0538303B1 Method for preparing cyclic sulphates
02/01/1994	US5283335 Herbicidal 2-(2-imidazolin-2-yl)-benzo-(6-membered)-heterocycles
01/1994
01/26/1994	EP0580553A2 Oxadiazine derivatives
01/26/1994	CN1081181A 吖啶衍生物 Acridine derivatives
01/22/1994	CA2100908A1 Method of preparation of physostigmine carbamate derivatives from physostigmine
01/20/1994	WO1994001436A1 Dioxcyclobutene derivatives as angiotensin ii antagonists
01/20/1994	CA2139930A1 Dioxycyclobutene derivatives as angiotensin ii antagonists
01/12/1994	CN1023483C Novel process for production of the dextrorotatory optical isomer of diastereomer a of ym-09730
01/06/1994	WO1994000458A1 N-substituted 3-azabicyclo[3.2.0]heptane derivates useful as neuroleptic agents, etc.
01/05/1994	CN1080169A Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
12/1993
12/29/1993	EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them
12/29/1993	EP0576211A2 Process for the synthesis of 4-hydroxy-5-halopyrrolo 2,3-D pyrimidine intermediates
12/29/1993	EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
12/28/1993	US5274176 Producing a 4-acetyltrialkylphenol form a trialkyl hydroquinone
12/28/1993	US5274123 Process for the preparation of cyclic sulphates
12/28/1993	CA1325634C Esters of hexahydro-8-hydroxy-2,6-methano-2h- quinolizin-3(4h)-one and related compounds
12/23/1993	WO1993025557A1 Process for the preparation of clavulanic acid
12/23/1993	WO1993025552A1 Process and intermediates for bis-aza-bicyclic anxiolytic agents
12/23/1993	WO1993025527A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
12/23/1993	DE4243287A1 N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use
12/23/1993	CA2117538A1 Process for the preparation of clavulanic acid
12/23/1993	CA2098694A1 Process for the synthesis of 4-hydroxy-5-halopyrrolo¬2,3-d\|pyrimidine intermediates
12/22/1993	EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors
12/22/1993	EP0574457A1 Antiviral nucleoside combination
12/15/1993	EP0573464A1 Process for preparing trans-piperidine-2,5-dicarboxylates.
12/14/1993	US5270324 Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
12/14/1993	CA1325209C Certain 2-substituted adenosine derivatives
12/12/1993	CA2160768A1 Process for the preparation of clavulanic acid
12/12/1993	CA2098168A1 Hydroxamic acid derivatives
12/09/1993	WO1993024491A1 Indolocarbazole imides and their use
12/02/1993	DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/01/1993	CN1022922C Process for preparing substantially anhyrous crystalline cetadroxil
12/01/1993	CN1022918C Herbicide compound containing 3-(substituted phenyl) pyrazole derivatives
11/1993
11/24/1993	EP0570838A1 S-triazine derivatives as light stabilisers
11/24/1993	CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/18/1993	EP0569564A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
11/18/1993	EP0569396A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion
11/16/1993	US5262430 Antidiabetic agent lowers blood glucose in mammals in type 2 non insulin dependent diabetes
11/11/1993	WO1993022283A1 Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines
11/09/1993	US5260307 Guanidine derivatives compositions and use
11/09/1993	CA2095499A1 Depot preparation
11/09/1993	CA1324137C Process for the preparation of quinoline carboxylic acids
11/03/1993	EP0568136A1 Indole-2-carboxylic acid derivatives
11/02/1993	US5258390 9-(3 cyanophenyl) hexahydro-1,8 acridinedione
10/1993
10/28/1993	WO1993021173A1 Taxol derivatives
10/28/1993	WO1993021159A1 Quinoline derivatives as leukotriene antagonists
10/28/1993	WO1993021153A1 Indole-2-carboxylic acid derivatives
10/28/1993	CA2130578A1 Taxol derivatives
10/28/1993	CA2118324A1 Substituted indolizino¬1,2-b\|quinolinones
10/26/1993	US5256682 Anxiolytic agents
10/20/1993	CN1022487C Novel pharmacological compounds
10/17/1993	CA2094076A1 Indole derivatives
10/17/1993	CA2094075A1 Indole derivatives
10/17/1993	CA2094073A1 Indole derivatives
10/16/1993	CA2093989A1 Reagent and catalytic process for clearing a protected function
10/14/1993	WO1993020052A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
10/13/1993	EP0565185A1 Quinoline derivatives as leukotriene antagonists
10/13/1993	CN1077193A N-5-protected-2,5-diamino-4,6-dichloropyrimidine and their process of preparation
10/12/1993	CA1323032C Process for preparing 2-guanidinothiazole derivatives
10/06/1993	EP0563345A1 Novel 4-arylpiperazines and 4-arylpiperidines
10/06/1993	CN1022324C Anhydrous crystal sodium salt of 5-chloro-3-(2-thenoyl)-2-oxyindole-1-carboxamide
09/1993
09/29/1993	EP0562049A1 Novel 4-arylpiperazines and 4-arylpiperidines
09/29/1993	EP0561973A1 Antiallergic compounds
09/29/1993	CN1076690A Sulfonamidocarboxamides
09/29/1993	CN1022243C Method of preparation of indole derivatives
09/28/1993	US5248685 5-lipoxygenase inhibitor
09/21/1993	US5247076 Imidazolidyl macrolides having immunosuppressive activity
09/21/1993	US5246935 Piperazinyl derivatives and methods of treating central nervous system ailments relating to the 5-ht2 receptor system
09/21/1993	US5246926 Cephalosporin derivatives
09/14/1993	US5245056 Production of oxetanones
09/14/1993	US5244903 Camptothecin analogs as potent inhibitors of topoisomerase I
09/14/1993	CA1322202C Process for the preparation of 1,2,-disulfone compounds
09/08/1993	EP0559046A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors
09/08/1993	CN1075957A Naphthalene derivative, preparation thereof and middle agent syntherised of same
09/07/1993	CA1321997C Pyridyl and pyrimidyl derivatives
09/02/1993	WO1993017008A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO[b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
09/02/1993	CA2128701A1 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo¬b\|-thiophene-2-carboxamides as inhibitors of cell adhesion
09/01/1993	EP0558156A2 Intermediates for 3-aminopiperidine derivates
08/1993
08/31/1993	US5240923 Treating glaucoma
08/25/1993	EP0557016A1 Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor
08/24/1993	CA1321597C2 Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof
08/24/1993	CA1321596C2 Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof
08/24/1993	CA1321595C2 Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof
08/24/1993	CA1321587C Quinoxaline compounds and their preparation and use
08/19/1993	WO1993016051A1 Arylalkoxyphenoxy-imidazoline compounds
08/19/1993	CA2129142A1 Arylalkoxyphenoxy-imidazoline compounds
08/18/1993	CN1075315A Method for semi-synthesis of taxalkane derivative with metal alkane oxide and beta-lactam
08/18/1993	CN1021817C Novel polyamine derivatives
08/10/1993	US5235053 Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates

1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 105